US 10533174
Splice-region antisense composition and method
granted A61KA61K38/00A61P
Quick answer
US patent 10533174 (Splice-region antisense composition and method) held by Sarepta Therapeutics, Inc. expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/00, A61P, A61P13/08, A61P17/00